Literature DB >> 25060793

Impact of phospholipid transfer protein on nascent high-density lipoprotein formation and remodeling.

Ailing Ji1, Joanne M Wroblewski1, Nancy R Webb1, Deneys R van der Westhuyzen2.   

Abstract

OBJECTIVE: Phospholipid transfer protein (PLTP), which binds phospholipids and facilitates their transfer between lipoproteins in plasma, plays a key role in lipoprotein remodeling, but its influence on nascent high-density lipoprotein (HDL) formation is not known. The effect of PLTP overexpression on apolipoprotein A-I (apoA-I) lipidation by primary mouse hepatocytes was investigated. APPROACH AND
RESULTS: Overexpression of PLTP through an adenoviral vector markedly affected the amount and size of lipidated apoA-I species that were produced in hepatocytes in a dose-dependent manner, ultimately generating particles that were <7.1 nm but larger than lipid-free apoA-I. These <7.1-nm small particles generated in the presence of overexpressed PLTP were incorporated into mature HDL particles more rapidly than apoA-I both in vivo and in vitro and were less rapidly cleared from mouse plasma than lipid-free apoA-I. The <7.1-nm particles promoted both cellular cholesterol and phospholipid efflux in an ATP-binding cassette transporter A1-dependent manner, similar to apoA-I in the presence of PLTP. Lipid-free apoA-I had a greater efflux capacity in the presence of PLTP than in the absence of PLTP, suggesting that PLTP may promote ATP-binding cassette transporter A1-mediated cholesterol and phospholipid efflux. These results indicate that PLTP alters nascent HDL formation by modulating the lipidated species and by promoting the initial process of apoA-I lipidation.
CONCLUSIONS: Our findings suggest that PLTP exerts significant effects on apoA-I lipidation and nascent HDL biogenesis in hepatocytes by promoting ATP-binding cassette transporter A1-mediated lipid efflux and the remodeling of nascent HDL particles.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  cholesterol; hepatocytes; nascent HDL; phospholipid transfer protein

Mesh:

Substances:

Year:  2014        PMID: 25060793      PMCID: PMC4141034          DOI: 10.1161/ATVBAHA.114.303533

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  34 in total

1.  ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport.

Authors:  J Klucken; C Büchler; E Orsó; W E Kaminski; M Porsch-Ozcürümez; G Liebisch; M Kapinsky; W Diederich; W Drobnik; M Dean; R Allikmets; G Schmitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency.

Authors:  X C Jiang; S Qin; C Qiao; K Kawano; M Lin; A Skold; X Xiao; A R Tall
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

3.  ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages.

Authors:  J F Oram; R M Lawn; M R Garvin; D P Wade
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

4.  Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.

Authors:  Kevin D O'Brien; Simona Vuletic; Thomas O McDonald; Gertrud Wolfbauer; Katherine Lewis; An-Yue Tu; Santica Marcovina; Thomas N Wight; Alan Chait; John J Albers
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

5.  Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells.

Authors:  Catherine M Desrumaux; Puiying A Mak; William A Boisvert; David Masson; Dwayne Stupack; Matti Jauhiainen; Christian Ehnholm; Linda K Curtiss
Journal:  J Lipid Res       Date:  2003-05-01       Impact factor: 5.922

6.  Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells.

Authors:  John F Oram; Gertrud Wolfbauer; Ashley M Vaughan; Chongren Tang; John J Albers
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

7.  Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.

Authors:  Xiao Ping Yang; Daoguang Yan; Chunping Qiao; Rui Jie Liu; Jer-Gin Chen; Juan Li; Martina Schneider; Laurent Lagrost; Xiao Xiao; Xian-Cheng Jiang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-10       Impact factor: 8.311

8.  Human plasma phospholipid transfer protein causes high density lipoprotein conversion.

Authors:  M Jauhiainen; J Metso; R Pahlman; S Blomqvist; A van Tol; C Ehnholm
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

9.  Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis.

Authors:  A R Tall; S Krumholz; T Olivecrona; R J Deckelbaum
Journal:  J Lipid Res       Date:  1985-07       Impact factor: 5.922

10.  Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in mice.

Authors:  Amirfarbod Yazdanyar; Wei Quan; Weijun Jin; Xian-Cheng Jiang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-11       Impact factor: 8.311

View more
  10 in total

1.  HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.

Authors:  Mark S Borja; Kit F Ng; Angela Irwin; Jaekyoung Hong; Xing Wu; Daniel Isquith; Xue-Qiao Zhao; Bryan Prazen; Virginia Gildengorin; Michael N Oda; Tomáš Vaisar
Journal:  J Lipid Res       Date:  2015-08-07       Impact factor: 5.922

Review 2.  A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

Authors:  Ryan E Temel; J Mark Brown
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

Review 3.  Is ABCA1 a lipid transfer protein?

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2018-01-05       Impact factor: 5.922

Review 4.  HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology.

Authors:  Robert S Rosenson; H Bryan Brewer; Philip J Barter; Johan L M Björkegren; M John Chapman; Daniel Gaudet; Daniel Seung Kim; Eric Niesor; Kerry-Anne Rye; Frank M Sacks; Jean-Claude Tardif; Robert A Hegele
Journal:  Nat Rev Cardiol       Date:  2017-08-10       Impact factor: 32.419

5.  Serum amyloid A is not incorporated into HDL during HDL biogenesis.

Authors:  Ailing Ji; Xuebing Wang; Victoria P Noffsinger; Drew Jennings; Maria C de Beer; Frederick C de Beer; Lisa R Tannock; Nancy R Webb
Journal:  J Lipid Res       Date:  2020-01-08       Impact factor: 5.922

Review 6.  Different Pathways of Cellular Cholesterol Efflux.

Authors:  Alexander D Dergunov; Veronika B Baserova
Journal:  Cell Biochem Biophys       Date:  2022-06-23       Impact factor: 2.989

7.  ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate.

Authors:  Bingqing Xu; Baiba K Gillard; Antonio M Gotto; Corina Rosales; Henry J Pownall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-10-26       Impact factor: 8.311

Review 8.  Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.

Authors:  Fatima Iqbal; Wendy S Baker; Madiha I Khan; Shwetha Thukuntla; Kevin H McKinney; Nicola Abate; Demidmaa Tuvdendorj
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

9.  Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity.

Authors:  Svetlana A Didichenko; Alexei V Navdaev; Alexandre M O Cukier; Andreas Gille; Patrick Schuetz; Martin O Spycher; Patrice Thérond; M John Chapman; Anatol Kontush; Samuel D Wright
Journal:  Circ Res       Date:  2016-07-19       Impact factor: 17.367

Review 10.  The role of the lymphatic system in cholesterol transport.

Authors:  Li-Hao Huang; Andrew Elvington; Gwendalyn J Randolph
Journal:  Front Pharmacol       Date:  2015-09-02       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.